Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology

Is Idiopathic Intracranial Hypertension a Brain Tumor?

At a Glance

No, idiopathic intracranial hypertension (IIH) is not a brain tumor or cancer. It is a condition where cerebrospinal fluid pressure is abnormally high without a physical mass. While it mimics tumor symptoms, imaging and fluid tests easily distinguish IIH so doctors can lower the pressure.

No, idiopathic intracranial hypertension (IIH) is not a brain tumor, and it is not cancer [1][2]. It is a condition where the pressure of your cerebrospinal fluid—the fluid that surrounds and cushions your brain and spinal cord—is abnormally high, but there is no physical mass or growth present [1].

The word “idiopathic” simply means that the exact root cause of this high fluid pressure is currently unknown [1][2].

Why Was It Called “Pseudotumor Cerebri”?

The historical name for IIH is pseudotumor cerebri, which literally translates to “false brain tumor” [1][3]. This older term can be terrifying for newly diagnosed patients, but it was actually created by doctors to describe exactly what the condition isn’t.

Your skull is a rigid, enclosed bone structure, meaning any extra volume inside it will raise the pressure [4]. A brain tumor raises pressure by adding a physical mass. In IIH, the pressure is elevated due to issues with the buildup, drainage, or flow of cerebrospinal fluid (CSF) rather than a mass [2][5]. Because the high fluid pressure in IIH produces the exact same physical symptoms a tumor would, doctors historically called it a “false tumor.”

How IIH Mimics a Tumor

Both a brain tumor and IIH lead to increased intracranial pressure (abnormally high pressure inside the skull) [1]. This shared elevated pressure is why the conditions can look identical before a full medical evaluation is performed. The shared symptoms include:

  • Severe headaches: Often the most common and persistent symptom [6].
  • Papilledema: Swelling of the optic nerves at the back of the eyes. This occurs when high fluid pressure in the brain pushes against the optic nerves [1][7]. While high pressure can threaten your vision over time, treatments for IIH are highly effective and specifically designed to protect your sight and prevent permanent damage [8].
  • Visual disturbances: This can include temporary blurring, a “curtain” effect, loss of peripheral vision, or double vision (diplopia) [6][9].
  • Pulsatile tinnitus: Hearing a rhythmic whooshing or heartbeat sound in your ears [9].
  • Nausea: Often accompanying the severe headaches [7].

While the symptoms are similar, doctors know to look for key differences: patients with a brain tumor often show localized neurological problems (like weakness on one side of the body), whereas patients with IIH typically have a completely normal neurological exam, aside from the swollen optic nerves [2].

How Doctors Know It Isn’t a Tumor

To be diagnosed with IIH, your medical team must confirm beyond a shadow of a doubt that your symptoms are not caused by a tumor, clot, or other physical abnormality [10][5]. Doctors use strict guidelines—often referred to as the modified Dandy criteria—to ensure a highly accurate diagnosis [2].

This diagnostic process requires a thorough, multi-step workup:

  1. Brain Imaging: You will usually undergo advanced imaging like an MRI and an MRV (magnetic resonance venography) [10]. These scans allow doctors to look inside the skull and verify that there are no masses, tumors, or structural lesions [11].
  2. Lumbar Puncture (Spinal Tap): Once imaging confirms your brain is structurally clear, a lumbar puncture is performed [12]. This procedure directly measures the opening pressure of your spinal fluid to confirm it is elevated, while also allowing doctors to test the fluid to ensure it is healthy and free of cancer cells or infection [2][12].

Only after confirming that your brain structure is clear, and ensuring your high pressure is not from a secondary cause, will doctors confidently diagnose you with idiopathic intracranial hypertension [5].

Moving Forward: Treatment is Not Cancer Care

Because the underlying problem is fluid pressure rather than a mass, the treatment strategies for IIH are entirely different from cancer care. Instead of chemotherapy or tumor removal, IIH is managed through medical and lifestyle interventions aimed at lowering pressure and saving your vision [13]:

  • Medications: Pressure-lowering medications, such as acetazolamide (Diamox), are often the first line of defense to decrease the production of cerebrospinal fluid [13].
  • Weight Management: Research shows a strong biological link between IIH and weight in women of childbearing age, though the exact physiological reason is still being studied. Because of this well-documented link, guided, compassionate weight management is a primary treatment that can significantly lower intracranial pressure and relieve symptoms [13].
  • Surgical Procedures: For severe cases that do not respond to medication or weight loss, surgical interventions like placing a shunt (a small tube to drain excess fluid) or venous sinus stenting (propping open a narrowed vein in the brain) can effectively relieve pressure [14].

Common questions in this guide

Why is idiopathic intracranial hypertension sometimes called pseudotumor cerebri?
The historical term pseudotumor cerebri translates to "false brain tumor." Doctors originally used this name because the high spinal fluid pressure in IIH causes the exact same physical symptoms as a brain tumor, even though no physical mass is present.
How do doctors know for sure that my symptoms aren't from a brain tumor?
Doctors use advanced brain imaging, such as an MRI and MRV, to confirm there are no tumors, clots, or physical masses inside your skull. They also perform a lumbar puncture (spinal tap) to measure your fluid pressure directly and ensure the fluid itself is healthy.
What are the common symptoms of idiopathic intracranial hypertension?
Common symptoms include severe headaches, temporary vision loss or double vision, nausea, and pulsatile tinnitus, which sounds like a rhythmic whooshing in the ears. It also causes swollen optic nerves, known as papilledema, which an eye doctor can detect.
How is idiopathic intracranial hypertension treated if it isn't cancer?
Instead of cancer treatments, IIH is managed by lowering the cerebrospinal fluid pressure to relieve symptoms and protect your vision. This is typically done using pressure-lowering medications like acetazolamide, guided weight management, or sometimes surgical shunts.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific imaging and tests, such as an MRI or lumbar puncture, were used to definitively rule out other causes for my high pressure?
  2. 2.How severe is my papilledema right now, and how frequently will I need comprehensive eye exams to ensure my optic nerves are safe?
  3. 3.What are the common side effects of pressure-lowering medications like acetazolamide, and how can I best manage them?
  4. 4.If weight management is part of my treatment plan, can you refer me to a specialist or nutritionist who understands the unique challenges of IIH?
  5. 5.What warning signs or sudden vision changes should prompt me to seek immediate medical attention?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Unilateral papilledema in idiopathic intracranial hypertension: A rare entity.

    Banerjee M, Aalok SP, Vibha D

    European journal of ophthalmology 2020; 1120672120969041 doi:10.1177/1120672120969041.

    PMID: 33143486
  2. 2

    Idiopathic Intracranial Hypertension in Children and Adolescents: An Update.

    Cleves-Bayon C

    Headache 2018; (58(3)):485-493 doi:10.1111/head.13236.

    PMID: 29194601
  3. 3

    [Idiopathic intracranial hypertension].

    Bäuerle J, Egger K, Harloff A

    Der Nervenarzt 2017; (88(2)):191-200 doi:10.1007/s00115-016-0279-6.

    PMID: 28083688
  4. 4

    Orthostatic Hemifacial Spasm in Idiopathic Intracranial Hypertension.

    Patrick MM, Postma GK, Bielling RAH, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2024; (44(4)):523-526 doi:10.1097/WNO.0000000000002187.

    PMID: 38863112
  5. 5

    Papilledema: A review of etiology, pathophysiology, diagnosis, and management.

    Xie JS, Donaldson L, Margolin E

    Survey of ophthalmology 2022; (67(4)):1135-1159 doi:10.1016/j.survophthal.2021.11.007.

    PMID: 34813854
  6. 6

    Idiopathic intracranial hypertension.

    Boyter E

    JAAPA : official journal of the American Academy of Physician Assistants 2019; (32(5)):30-35 doi:10.1097/01.JAA.0000554732.85914.91.

    PMID: 30969189
  7. 7

    Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report.

    Samara A, Ghazaleh D, Berry B, Ghannam M

    Journal of medical case reports 2019; (13(1)):94 doi:10.1186/s13256-019-2060-5.

    PMID: 30999940
  8. 8

    Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.

    Albrecht P, Blasberg C, Ringelstein M, et al.

    Journal of neurology 2017; (264(7)):1370-1380 doi:10.1007/s00415-017-8532-x.

    PMID: 28584914
  9. 9

    Idiopathic Intracranial Hypertension.

    Anderson M, Baird-Daniel E, Meyer RM, Levitt MR

    Neurosurgery clinics of North America 2024; (35(3)):287-291 doi:10.1016/j.nec.2024.02.001.

    PMID: 38782521
  10. 10

    Phenotyping non-idiopathic pseudotumor cerebri syndrome - A prospective cohort study.

    Svart K, Jensen RH, Høgedal L, et al.

    Cephalalgia : an international journal of headache 2022; (42(14)):1510-1520 doi:10.1177/03331024221120073.

    PMID: 35983777
  11. 11

    Neuroimaging findings in patients with idiopathic intracranial hypertension and cerebral venous thrombosis, and their association with clinical features.

    Onder H, Kisbet T

    Neurological research 2020; (42(2)):141-147 doi:10.1080/01616412.2019.1710408.

    PMID: 31910744
  12. 12

    Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension.

    Hansen NS, Korsbæk JJ, Yri HM, et al.

    Cephalalgia : an international journal of headache 2024; (44(4)):3331024241248210 doi:10.1177/03331024241248210.

    PMID: 38663903
  13. 13

    Effectiveness of Topiramate Versus Acetazolamide in the Management of Idiopathic Intracranial Hypertension: ASystematic Review and Meta-Analysis.

    Almaqhawi A, Alokley A, Alamri R, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(3)) doi:10.3390/medicina61030450.

    PMID: 40142261
  14. 14

    Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management.

    Wang MTM, Bhatti MT, Danesh-Meyer HV

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022; (95()):172-179 doi:10.1016/j.jocn.2021.11.029.

    PMID: 34929642

This page provides information on idiopathic intracranial hypertension for educational purposes only. Always consult your neurologist or healthcare provider for a proper diagnosis and personalized treatment plan.

Get notified when new evidence is published on Idiopathic intracranial hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.